Do you have pancreatic ductal adenocarcinoma that has come back after receiving standard therapy? If so, you may be able to participate in this gene therapy research study to learn more about using you own modified immune cells as possible treatment.

Have you been diagnosed with a B cell disease that has returned after your previous treatment or is not responding to your current treatment? If so, you might be able to take part in a study to see if a new treatment is safe and can help treat people with B-cell diseases.

You will be informed of the purpose of this study at the end of the survey.

The purpose of this study is to identify why households waste food. Using these causes of household food waste, we will work with participants to develop a comprehensive packet of tools that can be implemented in their daily lives to prevent food waste.

Do you have cervical cancer and are confused about health insurance or paying for your healthcare? We want to hear your thoughts on what might make it easier to navigate the financial side of cancer treatment. Your participation will help us to build a program to help cervical cancer patients like you. Compensation provided.

Do you have Non-Small Cell Lung Cancer? Have you previously been treated with Osimertinib? If so, you may be eligible for a trial comparing osimertinib in combination with other medications to treat your lung cancer. Please reach out if you're interested!

Have you been diagnosed with early stage triple negative breast cancer? We are asking you to take part in this research study because you have been diagnosed with triple-negative breast cancer (TNBC) and have recently completed preoperative chemotherapy in combination with pembrolizumab, followed by breast surgery. The chemotherapy plus pembrolizumab produced a pathologic complete response (pCR), meaning that no remaining cancer was found during your breast surgery.

In this project, we want to learn more about transgender and nonbinary individuals' sexual satisfaction. Sexual satisfaction is a prominent indicator of an individual's well-being and satisfaction with life. Current research focuses mainly on cisgender heterosexual populations. By focusing on people who identify under the nonbinary umbrella, in addition to binary-identifying trans people, we hope to examine how gender, the sociopolitical world, and a person's sexual satisfaction all intersect.

Finding new drugs is a long, expensive process. Drug repurposing, using an old drug for a new disorder, can make this process shorter and cheaper, and can occur by chance when a patient has two medical conditions that are treatable by the same drug. We hope that including you, the consumer, as a partner in drug development through self-report of unexpected benefits from medicinal agents could identify some with potential for repurposing. Your responses to a short Social Media survey may help you and others in the future.

Have you been diagnosed with breast cancer? If so, you may be able to take part in a research study for the collection of tumor specimens and genomic DNA from patients with early or metastatic breast cancer.